COVID-19 Response: Guidance for Researchers

This page contains important information about research operations.

Please refer to the University of Calgary’s Emergency Management website for up-to-date information about the university’s COVID-19 Response.

This page is for: faculty, postdocs, students, and staff engaged in research

Updated: March 27, 2020 11:30 a.m.

As of March 21, the University of Calgary issued a directive for faculty, staff, postdocs, and students to work from home. Accordingly, all research teams and units must do their utmost to follow this directive to work remotely.

However, it is possible for allowances to be made for critical research, scholarship and creative activities to continue on site.

Please review the message from the Vice-President (Research) and read the section below titled Critical Research Designation for details. 

On this page:

This page addresses key considerations for all researchers, followed by more specific recommendations and information on relevant issues:

  • Critical Research Designation

  • External requests for COVID-19 supplies

  • Summer studentships

  • Wet labs

  • Dry labs

  • Clinical settings 

  • Community-based research

  • Animal care

  • Human ethics 

  • Grants and Contracts FAQ

Critical Research Designation

For selected research activities to proceed on campus, they must be registered and approved by the University.

If you have not done so, please read the message from the Vice-President (Research) issued on 21 March 2020.

a. All researchers are asked to continue as much of their work as is feasible in a virtual or work-from-home setting. If you are able to do all of your work in this manner, only requiring access to online systems, you do not need to take further action.

b. Please evaluate whether you are able to shut down the on-campus portion of your work, and focus on work that can be done from home for the duration of the COVID-19 situation. However, if your work depends on having individuals work on campus, or access to on-campus infrastructure (either in your own on-campus workspace or shared facilities), then please carefully read the following sections.

If you have critical research, scholarship or creative work requiring access to on-campus facilities or infrastructure, then you must take action now so the University can review and approve your access to campus.

Similarly, if you are reducing or shutting down your work on campus, but must continue the operation of infrastructure on campus that requires maintenance or attention (e.g. sample storage system that requires regular liquid nitrogen refills, or an experimental apparatus that cannot be easily shut down), you must take action to maintain your access to campus in the event of wider access restriction.

CRITICAL RESEARCH

The University of Calgary currently considers critical research to be research, scholarship, or creative work that satisfies one or more of the following criteria:

  1. Research that is part of the Canadian COVID-19 Rapid Response Research Grants Program;
  2. Other time-sensitive COVID-19 related research that is vital to dealing with the current COVID-19 pandemic;
  3. Clinical Research in which participant health might be put at risk if the program is suspended;
  4. Ongoing research in which significant amounts of data would be completely lost or compromised, if the experiment or project was terminated early/suddenly;
  5. Research contract work that can be undertaken while meeting COVID-19 safety principles and in which contract deliverables must be met in order to continue funding.

CRITICAL RESEARCH INFRASTRUCTURE AND SERVICES

The University of Calgary currently considers critical research infrastructure and services to be those that satisfy one or more of the following criteria:

  1. Research infrastructure or services identified as required in support of critical research;
  2. Research infrastructure or services required to ensure human health and safety;
  3. Research infrastructure or services required to ensure animal health and safety;
  4. Research infrastructure that cannot be shut down in a timely manner (less than one day) without significant risk of damage or destruction of the infrastructure in question. This includes sample/material storage infrastructure requiring regular maintenance or consumable replenishment.

If you feel that your on-campus work must continue and it meets the criteria outlined above, then you must complete the following approval process.

Approval from your Associate Dean (Research) (ADR) or Department Head (if applicable) and the Office of the Vice-President (Research) is required to ensure that your team can access campus during this time.

Principal Investigator (or their designate) should initiate the following process:

  1. Step 1

    Download the Critical Research Designation Form. 

    All fields are required. 

  2. Step 2

    E-mail the completed Critical Research Designation Form to your Associate Dean Research AND, if you have one, your Department Head. Please send to both simultaneously as their reviews may be completed in parallel.

  3. Step 3

    Your ADR and Department Head (if applicable) will review your Critical Research Designation Form against the criteria above, and either endorse or decline to endorse the designation.

    Regardless of their decisions, your Critical Research Designation Form will be forwarded to the VPR Office at avpr@ucalgary.ca where the final decision will be made. 

     

    For Associate Deans Research and Department Heads:

    We ask that ADRs and Department Heads coordinate with each other (in departmentalized Faculties)

  4. Step 4

    If your Critical Research Designation is approved, you will receive a notification from the VPR Office. Approval means that your work and the individuals involved will be registered with the University of Calgary. 

Important:

  • You must submit a new/revised form if the details of your work changes.
  • Critical Research Designation is required if you wish to continue working on campus when access is restricted.
  • The University of Calgary may withdraw Critical Research Designation if conditions change. Note that a campus shut-down may occur abruptly, particularly if an order comes from government.

Contact avpr@ucalgary.ca with questions about the Critical Research Designation process.

 

As of March 21, 2020, all members of the university community have been asked to work from home. No one is obligated to work on campus, even in cases where there is a Critical Research Designation. Be sure that you communicate this point to your team, and support those who do not feel comfortable to work on campus.

 If any individual is feeling inappropriately pressured to carry out on-campus research, scholarship, or creative work, they should contact one of:

  • Office of the Vice-President (Research) at vpr@ucalgary.ca
  • Dean of Graduate Studies at deangrad@ucalgary.ca,
  • Or, if they prefer to report the concern confidentially, they can do so through the Office of Equity, Diversity and Protected Disclosure:

External requests for COVD-19 Supplies

In the interest of efficiency and to avoid duplicating efforts, the Office of the Vice-President (Research) will be coordinating institutional contributions for requests from external agencies for COVID-19 supplies, including reagents and personal protective equipment (PPE).

If you receive or have received a request of any kind for COVID-19 supplies, please contact Eoin O’Grady, Manager, Laboratory Safety, with details of the request and any timelines associated.

Personal Protective Equipment

We are recording "bulk" stocks of PPE. If you have a stock of PPE items, please contact Eoin O’Grady with a list of the PPE items that you have, and the number of units. 

Reagents

There is now an urgent need for reagents for use in provincial COVID-19 testing. If you have any of the reagents listed below, contact Eoin O’Grady and Benedikt Hallgrimsson specifying the name of the PI, location and quantities available. 

Reagents, Product ID, Supplier

  • Magmax Lysis/Binding solution concentrate, AM8500, LIFE TECHNOLOGIES
  • Magmax Wash Buffer 1, AM8504, LIFE TECHNOLOGIES

  • 5X Magmax RNA beads, AMB18365, LIFE TECHNOLOGIES

  • ABI Magmax mirvana total RNA isolation kit, a27828, ThermoFisher


Summer studentships

The University of Calgary recognizes the value of the student research, scholarship, and training experiences that typically takes place over the summer, including:

  • University of Calgary research programs such as PURE
  • Externally funded programs through agencies such as NSERC, CIHR, and Alberta Innovates
  • Principal Investigators who hire students with grant funds
  • University units who hire students with operating funds

At this time, the University of Calgary is aiming to avoid cancelling summer student opportunities wherever possible. We encourage supervisors and co-ordinators for all such programs to explore opportunities for virtual experiences for students (for example: literature reviews, data analysis, interviews, group work). Unfortunately, new students will not be permitted to do work on campus while restrictions are in place, even in areas that have received Critical Research Designation.

Decisions about specific programs are being made. Students, supervisors and co-ordinators are encouraged to explore options available to them.

Supervisors and co-ordinators are welcome to contact either the Office of the Provost or the Office of the Vice-President (Research) for guidance an appropriate course of action for your program.


Guidance for all researchers

Please consider all of the information below in the context of the work-from-home instructions issued on March 21, 2020.

Review the Critical Research Designation section above, if you have not done so already.

  • Be aware of current guidelines from AHS on how to protect others and yourself.
  • Wash your hands regularly according to guidelines including when you enter and leave your research facility, and when returning home at the end of the day.
  • Be prepared for the possibility of core facilities and other fee-for-service resources becoming unavailable. 
  • Be prepared for delays in supply chain, including shortage of Personal Protective Equipment.
  • Be prepared for delays in services provided by vendors.  If you returned from travel abroad after March 12, be aware that a 14-day self-isolation period is required upon your return.
  • Please work from home whenever possible and limit your presence in research facilities and in the work spaces on campus. Specifically, i.e. only go to your research facility on those days when critical work has to occur in your laboratory, or when the visit of a research participant cannot be postponed or conducted virtually.
  • If you are working in your lab/workshop, try to keep a 2-meter separation between active work areas.
  • Any in-person group activities including thesis defenses, mentorship committee meetings, seminars, journal clubs, laboratory meetings and hiring interviews should be canceled or held as virtual meetings by telephone, Skype, Zoom or similar. UCalgary now has an institutional license for Zoom.
  • Although there are currently no plans to close the university, this could change in the future with very little or no notice.  Further, individual COVID-19 cases could lead to closure of University buildings with no notice at all. Therefore, please take measures to ensure that your unit is prepared for the possibility of a closure at the end of each day.
  • Make sure all your data and files are accessible from your home computer systems so that you can work from home. Please ensure that all privacy regulations are respected.
  • If you have a UCalgary laptop, please take the laptop and its power supply home with you at the end of each working day.
  • Consider whether there are specific applications that you would need to install on your personal computer in order to work from home.
  • The University is providing a number of IT options for accessing shared drives from home or even remote log-in to desktop machines.  However, these tools require advance set-up of University devices. Visit the ‘Working and Learning from Home’ website for details, including steps you must take prior to working remotely.
  • Think carefully before initiating new experiments: consider the time required to complete them as well as the cost and inconvenience if they were interrupted before completion.
  • Unit leaders should ensure that they have up-to-date contact information including personal mobile telephone numbers for all staff.
  • Unit leaders should consider communicating with each other about opportunities to mitigate the impact of illness or self-isolation, such as by sharing staff between units.

Graduate students

Graduate students are encouraged to visit the Faculty of Graduate Studies website.

Supervisors are encouraged to review guidelines for effective remote supervision, provided by the Faculty of Graduate Studies. 

Guidance for specific types of research during COVID-19 response

  • Principal Investigators must ensure Lab Placard is current and After Hours Contacts are current in Chematix.
  • Identify procedures, processes and equipment that require ongoing personnel attention (e.g. glove boxes, heating/cooling systems, supplies of liquid nitrogen/helium, compressed gases, etc.)
  • Be prepared for building/lab/workshop access to be reduced or removed. 
  • Be prepared for scenarios in which access may only be allowed for key personnel to enable safe shutdown of experiments OR essential maintenance to critical equipment that could otherwise lead to increased risk of an incident.
  • Review/prepare laboratory procedures for long term shutdown of experimental systems that cannot be left unattended. Ensure that these protocols can be initiated and completed quickly should they be required. 
  • Identify and train key personnel to perform safe shutdown or essential equipment maintenance.
  • If you do not have experiments planned, work from home. This will facilitate social distancing in labs.
  • If you are working in your lab/workshop, try to keep a 2-meter separation between active work areas.
  • Lab personnel working with animals are asked to refer to animal care recommendations relating to the current COVID-19 situation.
  • Increase disinfection of lab/workshop areas including benches, chairs, common equipment / areas – especially should you be notified of personnel who become ill due to COVID-19.
  • Prioritize critical activities. 
  • Identify any activities that can be ramped down, curtailed, or delayed.
  • Consider installing remote control monitoring devices for critical equipment – monitoring which would otherwise be conducted by personnel (e.g. -80⁰C freezers, liquid nitrogen storage Dewars, incubators).
  • Label, secure and store hazardous materials such that hazards are removed/controlled for other personnel who may need to enter at short notice.
  • Avoid initiating long-term (e.g. overnight) unattended experiments. Post signage, if required.
  • Regularly dispose of hazardous wastes using Chematix.
  • Lock labs/workshops when unoccupied.
  • Coordinate personnel to avoid Working Alone situations.
  • Please keep in mind that activities in certain research core facilities such as imaging and mass spectrometry services may be compromised if facility staff are either ill or under self-isolation. If you have staff who may be able to assist, please contact the research core facilities managers.
  • Cross-train personnel or coordinate with colleagues with similar activities to provide support.
  • Biosafety Committee authorization is required prior to performing research with the virus causing COVID-19 (including accepting patient samples). Contact biosafety.officer@ucalgary.ca.   
  • For research involving human ethics, the CFREB and CHREB advise investigators to consider if their research protocols can be modified or delayed to limit unnecessary personal contacts. Specifically, for some research activities, in-person participant interactions could be reduced and/or replaced with telephone or online communication.
  • While TCPS 2 typically requires review and approval of modifications prior to implementation, an exception can be made where the change is necessary to eliminate an immediate risk to participant(s) (Article 6.15). Such changes may be implemented but must be reported to the REB at the earliest opportunity (within 5 business days as a guide).
  • If your unit administers resources that researchers, including trainees, may need to access in order to complete their studies, please give some thought to how remote access could be arranged (for example, to datasets).
  • The University is providing a number of IT options for accessing shared drives from home or even remote log-in to desktop machines.  However, these tools require advance set-up of University devices.  Visit the Working and Learning from Home website for details, including steps you must take prior to working remotely.
  • Please postpone any in-person study visits, focus groups, interviews etc and where possible conduct these as virtual meetings by telephone, Skype, Zoom or similar. UCalgary now has an institutional license for Zoom.
  • Monitoring visits: Effective March 27th, on-site monitoring visits are no longer permitted for pharma sponsored as well as investigator initiated trials. Monitoring visits can either be deferred or remote monitoring can be arranged. Memo: Clinical Trials Remote Monitoring and Study Status Updates during the COVID-19 Pandemic 
  • When research staff are in AHS space, all AHS policies and procedures must be followed including infection prevention and control practices and workplace health and safety rules. Please see the latest guidance from AHS on research in AHS facilities.
  • If research staff are feeling unwell or have even mild symptoms, we request that the staff do not enter any AHS space. If COVID-19 is known or suspected, call 8-1-1 and please visit the AHS website for the latest developments.
  • Limit personal contacts, laboratory visits or trips into clinics and hospitals. If research activity in an AHS area is unavoidable, please follow all AHS Infection Prevention and Control (IPC) guidelines and procedures. If there is any uncertainty, the AHS Health System Access team can connect you with the appropriate IPC representative for a consultation.
  • Do not initiate any new non-essential clinical studies.
  • AHS Health System Access will prioritize the processing of administrative approvals for studies related to essential clinical studies or COVID-19 response and/or treatment testing.
  • For non-critical approval requests, please expect a longer than usual processing time, operational approvals involving Emergency Departments and/or inpatient areas will be suspended until further notice.
  • The CFREB and CHREB advise investigators to consider if their research protocols could be modified or delayed, to limit personal contacts, laboratory visits or trips into clinics and hospitals. Specifically, in some research settings in-person participant interactions could be reduced and/or replaced with telephone or online communication.
  • While TCPS 2 typically requires review and approval of modifications prior to implementation, an exception can be made where the change is necessary to eliminate an immediate risk to participant(s) (Article 6.15). Such changes may be implemented but must be reported to the REB at the earliest opportunity (within 5 business days as a guide).
  • The Heritage Medical Research (HMRC) will remain open but with a reduced capacity. 
  • Operation of the HMRC facility is following AHS guidance.
  • Only patients and study monitors who pass the AHS screening test will be permitted to enter HMRC. Please check the HMRC website for further guidance.
  • HMRC may experience short-term closures due to COVID-19 exposure in its facilities or due to temporary staff shortage (arrangements are being made to train casual staff to cover absences due to illness or self-isolation).
  • The FMC ICU clinical trials unit facility will be unavailable until further notice
  • Consider which, if any, study visits could be canceled, delayed or held virtually as opposed to those which must proceed in-person (for example, administration of medication assessments that are clinically important). UCalgary now has an institutional license for Zoom.
  • If you anticipate the need for ongoing study visits to administer study drug or facilitate study assessments, consider alternating attendance of your study staff at study visits.  This will ensure that trained study staff remain available in case a study patient is found to have been infected with or exposed to COVID-19.
  • If study staff are exposed to a patient, study monitor or employee who is later found to have been infected with or exposed to COVID-19, the study staff member must self-isolate for 14 days.
  • Consider checking with Study Sponsors regarding their expectations, including how protocol violations should be handled and any special reporting requirements.
  • Biosafety Committee authorization is required prior to performing research with the virus causing COVID-19 (including accepting patient samples). Contact biosafety.officer@ucalgary.ca.   
  • For research involving human ethics, the CFREB and CHREB advise investigators to consider if their research protocols could be modified or delayed, to limit non-essential personal contacts in the community setting. Specifically, for some research, in-person participant interactions could be reduced and/or replaced with telephone or online communication.
  • While TCPS 2 typically requires review and approval of modifications prior to implementation, an exception can be made where the change is necessary to eliminate an immediate risk to participant(s) (Article 6.15). Such changes may be implemented but must be reported to the REB at the earliest opportunity (within 5 business days as a guide).
  • Please postpone any in-person contact with study subjects, including study visits, focus groups, interviews etc and advise your collaborators in the community to do the same. Where possible, these in-person meetings should be rescheduled as virtual meetings by telephone, Skype, Zoom or similar. UCalgary now has an institutional license for Zoom.

 

Human Ethics Guidance

Human Ethics Guidance from CFREB and CHREB during COVID-19

In light of the COVID-19 outbreak, the CFREB and CHREB advise investigators to consider if their research protocols could be modified or delayed, to limit personal contacts, laboratory visits or trips into clinics and hospitals. Specifically, in some research settings in-person participant interactions could be reduced and/or replaced with telephone or online communication. Considerations include the nature of your protocol, the type of participants engaged in the research, and any additional risk that may arise by switching from in-person to virtual communication. Revised participant consents or consent addendums may be required (e.g., to update privacy considerations with use of different communication channels).

Where research staff are feeling unwell – particularly those who interact with research participants – it is recommended to stay home to prevent transmission of illness. If COVID-19 is known or suspected, AHS protocols should be followed:https://www.albertahealthservices.ca/topics/Page16944.aspx.

While TCPS 2 typically requires review and approval of modifications prior to implementation, an exception can be made where the change is necessary to eliminate an immediate risk to participant(s) (Article 6.15). Such changes may be implemented but must be reported to the REB at the earliest opportunity (within 5 business days as a guide). For industry-sponsored clinical trials, researchers should also be working with the study sponsors to consult where possible to implement any changes.

A reminder that where the research involves physical assessments and use of equipment (e.g., metabolic carts, facemasks, mouthpieces, noseclips, straps, turbines, valves, tubing, cannula, treadmills, etc.) disinfection according to manufacturer’s standards where applicable is paramount and use of single use accessories is advisable. In the absence of manufacturers standards, thorough cleaning between participants is advised.

Memos

Please contact the appropriate Research Ethics Board with any questions:

CFREB (Conjoint Faculties Research Ethics Board) cfreb@ucalgary.ca

CHREB (Conjoint Health Research Ethics Board) chreb@ucalgary.ca

Ethics FAQ

Q: When do I report revisions to my research protocol that were made to eliminate immediate hazards to human participants?

A: The changes should be reported to the REB as soon as possible, preferably within 5 business days. We will request written justification for a delay of more than 5 business days.

Q: When can I make changes to my protocol without prior notice to or approval from the REB?

A: Should you determine that changes in your procedures are required, you can implement them immediately, without prior notice to or approval from the REB when they are necessary to eliminate increased risk due to the COVID-19 pandemic to the human participants (TCPS2 Article 6.15). 

Q: How do I report revisions to my research protocol that were made to eliminate immediate hazards to human participants

A:  If this is a temporary change to your study, please submit a reportable event in IRISS. In the submission, please specify what changes you are making as a result of the COVID-19 health crisis. 

  • If your reportable event is a Protocol Violation/Deviation, please note that only sections 1.0 and 2.0 should be completed. See the Reportable Events guidance document for more details.

If the amendment/modification to the protocol is not likely to be reverted, and you plan to continue the research indefinitely with the new changes, a Modification should be submitted.

Q: My research is taking place on the University of Calgary campus. What do I need to think about? How should I proceed?

A: For clinical research taking place in the AHS environment and/or accessing AHS resources, the researcher should refer to AHS Research Guidance. Contact research.administration@ahs.ca with questions. 

For all other research, please use the UCalgary Events Risk Management Tool, or contact COVID19@ucalgary.ca 

Q: Will human ethics applications be reviewed and approved by the Research Ethics Board (REB)?

A: The Research Ethics and Compliance team, along with the Conjoint Health Research Ethics Board (CHREB) and Conjoint Faculties Research Ethics Board (CFREB) remain operational. If the situation changes, turn-around times may lengthen, as applications focused on  COVID-19 may be prioritized.

Please contact chreb@ucalgary.ca or cfreb@ucalgary.ca if you have a COVID-19- related expedited review request

Q: How do I request an expedited review of a new REB application or a modification to an existing application during the COVID-19 pandemic?

A: Please note that the Boards are experiencing a high volume of requests relating to COVID-19. Requests for a priority review of new applications or modifications to expand study objectives during the COVID-19 pandemic must be made in writing to the Chair of your designated Board. 

Applications will be prioritized for review where the study has the potential to contribute to the prevention, diagnosis, treatment or care of COVID-19.  

Other studies (e.g., observational, survey or qualitative research examining the impact of the pandemic on various populations) will be prioritized based on the availability of REB resources. 

Please submit your request for priority with a short description of your study to the appropriate Board:

Grants and Contracts FAQ

Q: Will agencies be offering extensions to grant application deadlines, and/or grant end dates?

A: Research Services is in regular contact with funders and will inform the campus community immediately of any changes to deadlines through the Research Communications email list as well as by updating the Funding Deadline calendar. Tri-council has indicated they will be reviewing information on a program-by-program basis and will be communicating measures to be taken in the coming days.

NSERC has released a bulletin update on March 17, 2020 with program specific information. 

NSERC/SSHRC have indicated that they will approve, on request, extensions to spend existing grant funds of up to 12 months for grants ending on or before March 31, 2021. This provision applies to all grants, regardless of whether they have received a previous time extension of any length for any reason (including, where applicable, automatic extensions).

If you have concerns about a particular program or competition, please contact rsogrants@ucalgary.ca.

Q: Are there still people available to sign off/approve my grant application? If so who, and what are the timelines?

A: As long as the University is open, Research Services will be working to process grant applications. This will be a priority task in RSO.

Please be aware that we may have reduced capacity depending on staff situation, so please submit with as much time as possible in advance of the agency deadline. Please check with your Department Head and Associate Dean (Research) office for department and faculty levels approvals in advance of submitting to RSO. You can contact rsogrants@ucalgary.ca for questions about external grants and ipd@ucalgary.ca for institutional programs such as CFI and NFRF competitions. 

Q: Will NSERC (or CIHR or SSHRC) cover non-refundable travel fees if my meeting or conference is cancelled?

A: The three federal granting agencies have confirmed that the reimbursement of non-refundable travel fees from agency funds is acceptable considering the impacts of COVID-19. This applies to the travel of both principal investigators and research personnel, when cancellation occurs as a result of various factors such as cancelled conferences, travel advisories, or personal choice due to health or other concerns.

Q: I have a research contract under way and a key team member is now unable to work and I’m not sure when she’ll be back. The contract has set deadlines for certain deliverables and completion. I don’t think I’ll be able to meet the deadlines. What should I do?

A: As soon as you are certain that the original time frame cannot be met (or any other important element such as budget or deliverables) contact  your sponsor, explain the circumstances, and ask if changes to the project can be made. 

It is likely that the sponsor will understand the problem and work with you to create new deadlines, budgets or deliverables. Once you have reached that point, contact RSO Legal & IP so a formal amendment to the contract can be made.

Don’t forget this last step: if there is no written amendment to the original agreement, the changes to the contract you discussed with the sponsor may not be valid.

Q: I have a research contract under way and the sponsor failed to make a scheduled payment required in the agreement. What should I do?

A: If a sponsor has missed a scheduled payment it is important for you, as PI, to act quickly. Contact the sponsor and ask if they have any concerns with the project. Let them know a payment was missed and ask when it will be made.

If you learn that the sponsor has encountered financial difficulty and cannot make the payment anytime soon ask if the project should be cancelled or the time period re-negotiated. Once you have this information, contact RSO Legal & IP so a Notice of Termination can be issued or a formal amendment to the contract can be made.   

If you are certain that the contract time period will be ended or renegotiated then stop work on the project as soon as possible to avoid incurring additional expenses. Remember, if the sponsor doesn’t pay the project may become an overexpenditure for which you are personally responsible.

If you have other funds to support the continuation of work, you may decide to continue the project but if the sponsor is refusing payment don’t continue to provide reports.

Q: I have tried to contact the sponsor to discuss changes to my project but I am not getting any response to emails or voice messages. What should I do?

A: Contact RSO Legal & IP and explain the situation. A formal communication from the University will be sent to the sponsor asking for a response before a certain deadline. If no response is received to that letter the next step may be to issue a Notice of Termination of the agreement.

Q: The sponsor of my research project sent me an email asking for early termination of the project. What do I do now?

A: Contact RSO Legal & IP and explain the situation. They will contact the sponsor and determine if termination is the only remaining option. If so, then formal documentation to terminate the agreement will be processed. 

We know that determination of urgency vs. non-urgency of your potential research activities may not be straightforward. Furthermore, we recognize that you may have concerns relating to funding agency timelines.

The teams in the VPR Office and Research Services are available to assist you in considering the time-sensitivity of your planned research activities. We consider it likely that there will be funding agency allowances made for COVID-19 extensions and deferrals, and will advocate for this on your behalf when it is appropriate to do so.  

 

Contact

Questions or inquiries should be directed to avpr@ucalgary.ca

Please monitor this website for current information